Brd/BET Proteins Influence the Genome-Wide Localization of the Kaposi’s Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus Major Latency Proteins

The rhadinoviruses Kaposi’s Sarcoma-associated herpesvirus (KSHV) and murine gammaherpesvirus (MHV-68) persist in infected hosts in a latent state that is characterized by the absence of virus production and by restricted viral gene expression. Their major latency protein, the latency-associated nuclear antigen (kLANA for KSHV and mLANA for MHV-68), is essential for viral genome maintenance and replication and involved in transcriptional regulation. Both kLANA and mLANA interact with cellular chromatin-associated proteins, among them the Bromodomain and Extra Terminal domain (Brd/BET) proteins, which recruit cellular and viral proteins to acetylated histones through their bromodomains and modulate cellular gene expression. Brd/BET proteins also play a role in the tethering, replication, segregation or integration of a diverse group of viral DNA genomes. In this study we explored if Brd/BET proteins influence the localization of the LANAs to preferential regions in the host chromatin and thereby contribute to kLANA- or mLANA-mediated transcriptional regulation. Using ChIP-Seq, we revealed a genome-wide co-enrichment of kLANA with Brd2/4 near cellular and viral transcriptional start sites (TSS). Treatment with I-BET151, an inhibitor of Brd/BET, displaced kLANA and Brd2/4 from TSS in the viral and host chromatin, but did not affect the direct binding of kLANA to kLANA-binding sites (LBS) in the KSHV latent origin of replication. Similarly, mLANA, but not a mLANA mutant deficient for binding to Brd2/4, also associated with cellular TSS. We compared the transcriptome of KSHV-infected with uninfected and kLANA-expressing human B cell lines, as well as a murine B cell line expressing mLANA or a Brd2/4-binding deficient mLANA mutant. We found that only a minority of cellular genes, whose TSS are occupied by kLANA or mLANA, is transcriptionally regulated by these latency proteins. Our findings extend previous reports on a preferential deposition of kLANA on cellular TSS and show that this characteristic chromatin association pattern is at least partially determined by the interaction of these viral latency proteins with members of the Brd/BET family of chromatin modulators.

[1]  R. Trumbly,et al.  Bromodomain and extra-terminal domain (BET) proteins regulate melanocyte differentiation , 2020, Epigenetics & Chromatin.

[2]  P. Grandi,et al.  Click chemistry enables preclinical evaluation of targeted epigenetic therapies , 2017, Science.

[3]  Yuan Gao,et al.  The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency , 2017, Journal of Virology.

[4]  J. Miranda,et al.  Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps , 2017, The Journal of Biological Chemistry.

[5]  P. Filippakopoulos,et al.  Functions of bromodomain-containing proteins and their roles in homeostasis and cancer , 2017, Nature Reviews Molecular Cell Biology.

[6]  P. Lieberman,et al.  BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency , 2017, PLoS pathogens.

[7]  E. Robertson,et al.  Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues , 2017, PLoS Pathogens.

[8]  Shou-Jiang Gao,et al.  LANA-Mediated Recruitment of Host Polycomb Repressive Complexes onto the KSHV Genome during De Novo Infection , 2016, PLoS pathogens.

[9]  John Chilton,et al.  The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update , 2016, Nucleic Acids Res..

[10]  B. N. Devaiah,et al.  BRD4 is a Histone Acetyltransferase that Evicts Nucleosomes from Chromatin , 2016, Nature Structural &Molecular Biology.

[11]  T. Schulz,et al.  Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS , 2016, Proceedings of the National Academy of Sciences.

[12]  Z. Izsvák,et al.  Genome-wide Profiling Reveals Remarkable Parallels Between Insertion Site Selection Properties of the MLV Retrovirus and the piggyBac Transposon in Primary Human CD4+ T Cells. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  Mark S. Anderson,et al.  Brd4 bridges the transcriptional regulators, Aire and P-TEFb, to promote elongation of peripheral-tissue antigen transcripts in thymic stromal cells , 2015, Proceedings of the National Academy of Sciences.

[14]  T. Schulz,et al.  Generation of high-titre virus stocks using BrK.219, a B-cell line infected stably with recombinant Kaposi's sarcoma-associated herpesvirus. , 2015, Journal of virological methods.

[15]  T. Schulz,et al.  The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA , 2015, Proceedings of the National Academy of Sciences.

[16]  C. Wahlestedt,et al.  The BET Bromodomain Inhibitor I-BET151 Acts Downstream of Smoothened Protein to Abrogate the Growth of Hedgehog Protein-driven Cancers* , 2014, The Journal of Biological Chemistry.

[17]  Yajie Yang,et al.  LANA Binds to Multiple Active Viral and Cellular Promoters and Associates with the H3K4Methyltransferase hSET1 Complex , 2014, PLoS pathogens.

[18]  A. McBride,et al.  Papillomavirus Genomes Associate with BRD4 to Replicate at Fragile Sites in the Host Genome , 2014, PLoS pathogens.

[19]  Yuan Gao,et al.  Kaposi's Sarcoma-Associated Herpesvirus-Encoded LANA Interacts with Host KAP1 To Facilitate Establishment of Viral Latency , 2014, Journal of Virology.

[20]  Meghan M. Holdorf,et al.  Site-Specific Association with Host and Viral Chromatin by Kaposi's Sarcoma-Associated Herpesvirus LANA and Its Reversal during Lytic Reactivation , 2014, Journal of Virology.

[21]  William B. Smith,et al.  Genome-wide Determination of Drug Localization Nih Public Access Author Manuscript , 2022 .

[22]  Andrew J. Bannister,et al.  BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms , 2014, Leukemia.

[23]  R. Prinjha,et al.  Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762. , 2014, Blood.

[24]  C. Tepper,et al.  Biphasic Euchromatin-to-Heterochromatin Transition on the KSHV Genome Following De Novo Infection , 2013, PLoS pathogens.

[25]  F. Bushman,et al.  The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites. , 2013, Cell reports.

[26]  Shwu‐Yuan Wu,et al.  Brd4 Is Displaced from HPV Replication Factories as They Expand and Amplify Viral DNA , 2013, PLoS pathogens.

[27]  T. Schulz,et al.  A Structural Basis for BRD2/4-Mediated Host Chromatin Interaction and Oligomer Assembly of Kaposi Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus LANA Proteins , 2013, PLoS pathogens.

[28]  P. Lieberman,et al.  Molecular Basis for Oligomeric-DNA Binding and Episome Maintenance by KSHV LANA , 2013, PLoS pathogens.

[29]  M. A. Carrondo,et al.  Crystal Structure of the Gamma-2 Herpesvirus LANA DNA Binding Domain Identifies Charged Surface Residues Which Impact Viral Latency , 2013, PLoS pathogens.

[30]  A. Schambach,et al.  Bromo- and Extraterminal Domain Chromatin Regulators Serve as Cofactors for Murine Leukemia Virus Integration , 2013, Journal of Virology.

[31]  S. Verma,et al.  Comprehensive Analysis of LANA Interacting Proteins Essential for Viral Genome Tethering and Persistence , 2013, PloS one.

[32]  F. Bushman,et al.  BET proteins promote efficient murine leukemia virus integration at transcription start sites , 2013, Proceedings of the National Academy of Sciences.

[33]  P. Kellam,et al.  Activation of the B Cell Antigen Receptor Triggers Reactivation of Latent Kaposi's Sarcoma-Associated Herpesvirus in B Cells , 2013, Journal of Virology.

[34]  H. Kung,et al.  Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Latency-Associated Nuclear Antigen Regulates the KSHV Epigenome by Association with the Histone Demethylase KDM3A , 2013, Journal of Virology.

[35]  E. Robertson,et al.  H2AX Phosphorylation Is Important for LANA-Mediated Kaposi's Sarcoma-Associated Herpesvirus Episome Persistence , 2013, Journal of Virology.

[36]  R. Siliciano,et al.  BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism , 2013, Cell cycle.

[37]  J. Bradner,et al.  Recruitment of Brd4 to the Human Papillomavirus Type 16 DNA Replication Complex Is Essential for Replication of Viral DNA , 2013, Journal of Virology.

[38]  Vladimir B. Bajic,et al.  HOCOMOCO: a comprehensive collection of human transcription factor binding sites models , 2012, Nucleic Acids Res..

[39]  Qiang Zhou,et al.  The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation , 2012, Nucleic acids research.

[40]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[41]  Xin Wang,et al.  Bromodomain Protein Brd4 Plays a Key Role in Merkel Cell Polyomavirus DNA Replication , 2012, PLoS pathogens.

[42]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[43]  K. Kaye,et al.  Murine Gammaherpesvirus 68 LANA Acts on Terminal Repeat DNA To Mediate Episome Persistence , 2012, Journal of Virology.

[44]  ENCODEConsortium,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[45]  A. Gingras,et al.  Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family , 2012, Cell.

[46]  R. Davuluri,et al.  Identification of Host-Chromosome Binding Sites and Candidate Gene Targets for Kaposi's Sarcoma-Associated Herpesvirus LANA , 2012, Journal of Virology.

[47]  Manolis Kellis,et al.  ChromHMM: automating chromatin-state discovery and characterization , 2012, Nature Methods.

[48]  Peter A. DiMaggio,et al.  Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins , 2012, Genome Biology.

[49]  L. Aaltonen,et al.  KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition. , 2011, Cell host & microbe.

[50]  S. Robson,et al.  Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia , 2011, Nature.

[51]  S. Knapp,et al.  Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery. , 2011, Molecular bioSystems.

[52]  P. Bamborough,et al.  Discovery and characterization of small molecule inhibitors of the BET family bromodomains. , 2011, Journal of medicinal chemistry.

[53]  Jennifer A. Smith,et al.  The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3 , 2011, Molecular and Cellular Biology.

[54]  Philip Machanick,et al.  MEME-ChIP: motif analysis of large DNA datasets , 2011, Bioinform..

[55]  William Stafford Noble,et al.  FIMO: scanning for occurrences of a given motif , 2011, Bioinform..

[56]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[57]  C. Rice,et al.  Suppression of inflammation by a synthetic histone mimic , 2010, Nature.

[58]  B. Langmead,et al.  Aligning Short Sequencing Reads with Bowtie , 2010, Current protocols in bioinformatics.

[59]  T. Umehara,et al.  Structural implications for K5/K12‐di‐acetylated histone H4 recognition by the second bromodomain of BRD2 , 2010, FEBS letters.

[60]  P. Laird,et al.  Epigenetic Analysis of KSHV Latent and Lytic Genomes , 2010, PLoS pathogens.

[61]  T. Günther,et al.  The Epigenetic Landscape of Latent Kaposi Sarcoma-Associated Herpesvirus Genomes , 2010, PLoS pathogens.

[62]  Aaron R. Quinlan,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2022 .

[63]  Shigeyuki Yokoyama,et al.  Structural Basis for Acetylated Histone H4 Recognition by the Human BRD2 Bromodomain* , 2010, The Journal of Biological Chemistry.

[64]  Satoko Matsumura,et al.  The Latency-Associated Nuclear Antigen Interacts with MeCP2 and Nucleosomes through Separate Domains , 2009, Journal of Virology.

[65]  M. Geyer,et al.  Structures of the Dual Bromodomains of the P-TEFb-activating Protein Brd4 at Atomic Resolution* , 2009, The Journal of Biological Chemistry.

[66]  Tao Liu,et al.  CEAS: cis-regulatory element annotation system , 2009, Bioinform..

[67]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[68]  J. Stewart,et al.  The Interaction of the Gammaherpesvirus 68 orf73 Protein with Cellular BET Proteins Affects the Activation of Cell Cycle Promoters , 2009, Journal of Virology.

[69]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[70]  L. Frappier,et al.  The EBNA1 Protein of Epstein-Barr Virus Functionally Interacts with Brd4 , 2008, Journal of Virology.

[71]  Marcin Schmidt,et al.  Search for cellular partners of human papillomavirus type 16 E2 protein , 2008, Archives of Virology.

[72]  L. Frappier,et al.  The EBNA 1 Protein of Epstein-Barr Virus Functionally Interacts with Brd 4 , 2008 .

[73]  A. J. Kapasi,et al.  Inhibition of the Cyclin-Dependent Kinases at the Beginning of Human Cytomegalovirus Infection Specifically Alters the Levels and Localization of the RNA Polymerase II Carboxyl-Terminal Domain Kinases cdk9 and cdk7 at the Viral Transcriptosome , 2007, Journal of Virology.

[74]  Shwu‐Yuan Wu,et al.  The Double Bromodomain-containing Chromatin Adaptor Brd4 and Transcriptional Regulation* , 2007, Journal of Biological Chemistry.

[75]  M. Ballestas,et al.  Determination of Kaposi's Sarcoma-Associated Herpesvirus C-Terminal Latency-Associated Nuclear Antigen Residues Mediating Chromosome Association and DNA Binding , 2007, Journal of Virology.

[76]  A. Whitehouse,et al.  Herpesvirus Saimiri Episomal Persistence Is Maintained via Interaction between Open Reading Frame 73 and the Cellular Chromosome-Associated Protein MeCP2 , 2007, Journal of Virology.

[77]  Masami Horikoshi,et al.  Crystal Structure of the Human BRD2 Bromodomain , 2006, Journal of Biological Chemistry.

[78]  P. Howley,et al.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Interacts with Bromodomain Protein Brd4 on Host Mitotic Chromosomes , 2006, Journal of Virology.

[79]  S. Verma,et al.  Proteomic Analysis of the Kaposi's Sarcoma-Associated Herpesvirus Terminal Repeat Element Binding Proteins , 2006, Journal of Virology.

[80]  Shwu‐Yuan Wu,et al.  Brd4 links chromatin targeting to HPV transcriptional silencing. , 2006, Genes & development.

[81]  T. Schulz,et al.  Kaposi's Sarcoma-Associated Herpesvirus LANA-1 Interacts with the Short Variant of BRD4 and Releases Cells from a BRD4- and BRD2/RING3-Induced G1 Cell CycleArrest , 2006, Journal of Virology.

[82]  Jun Song,et al.  CEAS: cis-regulatory element annotation system , 2006, Nucleic Acids Res..

[83]  K. Luger,et al.  Kaposi’s Sarcoma-Associated Herpesvirus LANA Hitches a Ride on the Chromosome , 2006, Cell cycle.

[84]  D. Faller,et al.  Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines. , 2006, Journal of proteome research.

[85]  K. Luger,et al.  The Nucleosomal Surface as a Docking Station for Kaposi's Sarcoma Herpesvirus LANA , 2006, Science.

[86]  Yingle Liu,et al.  Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation , 2006, Molecular and Cellular Biochemistry.

[87]  S. Verma,et al.  Repeat Element Binding Proteins Sarcoma-Associated Herpesvirus Terminal Proteomic Analysis of the Kaposi ' s , 2006 .

[88]  P. Howley,et al.  Inhibition of E2 Binding to Brd4 Enhances Viral Genome Loss and Phenotypic Reversion of Bovine Papillomavirus-Transformed Cells , 2005, Journal of Virology.

[89]  T. Schulz,et al.  Brd2/RING3 Interacts with a Chromatin-Binding Domain in the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 (LANA-1) That Is Required for Multiple Functions of LANA-1 , 2005, Journal of Virology.

[90]  J. Brady,et al.  The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. , 2005, Molecular cell.

[91]  Qiang Zhou,et al.  Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. , 2005, Molecular cell.

[92]  K. Ozato,et al.  Interaction of Bovine Papillomavirus E2 Protein with Brd4 Stabilizes Its Association with Chromatin , 2005, Journal of Virology.

[93]  William Stedman,et al.  ORC, MCM, and Histone Hyperacetylation at the Kaposi's Sarcoma-Associated Herpesvirus Latent Replication Origin , 2004, Journal of Virology.

[94]  C. Lim,et al.  Mitotic Chromosome-Binding Activity of Latency-Associated Nuclear Antigen 1 Is Required for DNA Replication from Terminal Repeat Sequence of Kaposi's Sarcoma-Associated Herpesvirus , 2004, Journal of Virology.

[95]  P. Howley,et al.  Interaction of the Bovine Papillomavirus E2 Protein with Brd4 Tethers the Viral DNA to Host Mitotic Chromosomes , 2004, Cell.

[96]  Y. Kanno,et al.  Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. , 2004, Molecular cell.

[97]  M. Ballestas,et al.  The Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 N Terminus Is Essential for Chromosome Association, DNA Replication, and Episome Persistence , 2004, Journal of Virology.

[98]  S. Efstathiou,et al.  ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency. , 2003, The Journal of general virology.

[99]  Tom Misteli,et al.  The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[100]  L. Szekely,et al.  A Domain in the C-Terminal Region of Latency-Associated Nuclear Antigen 1 of Kaposi's Sarcoma-Associated Herpesvirus Affects Transcriptional Activation and Binding to Nuclear Heterochromatin , 2003, Journal of Virology.

[101]  D. Ganem,et al.  The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Permits Replication of Terminal Repeat-Containing Plasmids , 2003, Journal of Virology.

[102]  T. Ushiki,et al.  Chromosome Binding Site of Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Is Essential for Persistent Episome Maintenance and Is Functionally Replaced by Histone H1 , 2002, Journal of Virology.

[103]  M. Fujimuro,et al.  Protein Interactions Targeting the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus to Cell Chromosomes , 2002, Journal of Virology.

[104]  Jianhong Hu,et al.  Latency-associated Nuclear Antigen (LANA) Cooperatively Binds to Two Sites within the Terminal Repeat, and Both Sites Contribute to the Ability of LANA to Suppress Transcription and to Facilitate DNA Replication* , 2002, The Journal of Biological Chemistry.

[105]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[106]  Ming-Ming Zhou,et al.  Bromodomain: an acetyl‐lysine binding domain , 2002, FEBS letters.

[107]  L. Szekely,et al.  Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions. , 2002, The Journal of general virology.

[108]  G. Denis.  Duality in bromodomain-containing protein complexes. , 2001, Frontiers in bioscience : a journal and virtual library.

[109]  D. Faller,et al.  You bet-cha: a novel family of transcriptional regulators. , 2001, Frontiers in bioscience : a journal and virtual library.

[110]  G. Denis.  Bromodomain motifs and "scaffolding"? , 2001, Frontiers in bioscience : a journal and virtual library.

[111]  D. Faller,et al.  RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[112]  C. Boshoff,et al.  HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. , 2000, Blood.

[113]  T. Schulz,et al.  Latent Nuclear Antigen of Kaposi’s Sarcoma-Associated Herpesvirus Interacts with RING3, a Homolog of theDrosophila Female Sterile Homeotic (fsh) Gene , 1999, Journal of Virology.

[114]  E. Robertson,et al.  The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. , 1999, Virology.

[115]  Lei Zeng,et al.  Structure and ligand of a histone acetyltransferase bromodomain , 1999, Nature.

[116]  R. Horie,et al.  [Multicentric Castleman's disease]. , 1998, Ryoikibetsu shokogun shirizu.

[117]  M. Green,et al.  A novel, mitogen-activated nuclear kinase is related to a Drosophila developmental regulator. , 1996, Genes & development.

[118]  F. Sigaux,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.

[119]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[120]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.

[121]  A. Dalgleish,et al.  Kaposi's sarcoma. , 1991, British Journal of Cancer.

[122]  K. Marushige.  Activation of chromatin by acetylation of histone side chains. , 1976, Proceedings of the National Academy of Sciences of the United States of America.